1842676957299765Latent class cluster analysis to understand heterogeneity in prostate cancer treatment utilities
暂无分享,去创建一个
Salimah H. Meghani | Deborah W. Bruner | Alexandra L. Hanlon | Christopher S. Lee | Christopher S. Lee | S. Meghani | A. Hanlon | D. Bruner
[1] Ruth Etzioni,et al. Estimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence Trends , 2008, Biometrics.
[2] A. Tversky,et al. Prospect theory: an analysis of decision under risk — Source link , 2007 .
[3] D. Rubin,et al. Testing the number of components in a normal mixture , 2001 .
[4] A. Tversky,et al. Prospect theory: analysis of decision under risk , 1979 .
[5] C. Stocking,et al. Sex or survival: trade-offs between quality and quantity of life. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] W. Catalona,et al. Patient preferences for outcomes associated with surgical management of prostate cancer. , 2002, The Journal of urology.
[7] M. Diefenbach,et al. Prostate Cancer Risk Assessment Program , 1999 .
[8] B. Muthén,et al. Integrating person-centered and variable-centered analyses: growth mixture modeling with latent trajectory classes. , 2000, Alcoholism, clinical and experimental research.
[9] J. Merz,et al. Older Patients' Willingness to Trade Off Urologic Adverse Outcomes for a Better Chance at Five‐Year Survival in the Clinical Setting of Prostate Cancer , 1995, Journal of the American Geriatrics Society.
[10] Hein Putter,et al. Joint analysis of multiple longitudinal outcomes: Application of a latent class model , 2008, Statistics in medicine.
[11] D. Lubeck,et al. A review of measurement of patient preferences for treatment outcomes after prostate cancer. , 2002, Urology.
[12] J. Vermunt,et al. Latent class cluster analysis , 2002 .
[13] J. Eastham. Active surveillance for prostate cancer with selective delayed definitive therapy. , 2005, Clinical prostate cancer.
[14] G. Chapman,et al. Ethnic variation in localized prostate cancer: a pilot study of preferences, optimism, and quality of life among black and white veterans. , 2004, Clinical prostate cancer.
[15] G. Torrance. Utility measurement in healthcare: the things I never got to. , 2006, PharmacoEconomics.
[16] M. Wolf,et al. Patient preferences in prostate cancer: a clinician's guide to understanding health utilities. , 2005, Clinical prostate cancer.
[17] A. McCutcheon,et al. Latent Class Analysis , 2021, Encyclopedia of Autism Spectrum Disorders.
[18] J. Gornbein,et al. Predictors of utilities for health states in early stage prostate cancer. , 2001, The Journal of urology.
[19] Karen E Bremner,et al. A Review and Meta-Analysis of Prostate Cancer Utilities , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.
[20] M. Diefenbach,et al. Prostate cancer risk assessment program. A model for the early detection of prostate cancer. , 1999, Oncology.
[21] Susan T. Stewart,et al. Utilities For Prostate Cancer Health States in Men Aged 60 and Older , 2005, Medical care.
[22] G. Schwarz. Estimating the Dimension of a Model , 1978 .
[23] A. Godwin,et al. Prostate cancer risk assessment program: a 10-year update of cancer detection. , 2007, The Journal of urology.